摘要
目的:探讨奥德金治疗血管性痴呆的疗效和安全性。方法:将61例血管性痴呆患者随机分成研究组和对照组,两组于治疗前和治疗后2周行长谷川痴呆量表检查。研究组31例患者应用奥德金20ml加入0.9％氯化钠250ml,1次/日,静脉滴注,2周为1疗程;对照组30例应用血活素20ml加入0.9％氯化钠250ml,1次/日,静脉滴注,2周为1疗程。两组基础治疗相同..结果:研究组总有效率为67.74％,对照组为63.33％(P>0.05),均未发现不良反应。结论:奥德金治疗血管性痴呆安全有效。
AIM: To investigate the efficacy and safety of adegold in the treatment of vascular dementia .METHODS: 61 patients with vascular dementia were randomly divided into study group and control group.All patients underwent Hasegawa's Dementia Scale testing before and 2 weeks after treatment.31 patients in the study group were given adegold 20ml in 0.9% sodium chloride 250ml,intravenous drip,qd for 2 weeks.30 patients in the control group received solclseryl 20ml in 0.9% sodium chloride 250ml, intravenous drip, qd for 2 weeks.The basal therapy for both groups was completely identical .RESULTS: The total effective rate of adegold was 67.74% in the treatment of vascular dementia, which was significantly different from that of solclseryl(63.33% , P >0.05) .No adverse drug reactions were found .CONCLUSION: Adegold is a new safe drug with curative effect and reliability in treatment of vascular dementia.
出处
《中国医院用药评价与分析》
2001年第4期229-230,共2页
Evaluation and Analysis of Drug-use in Hospitals of China
